Skip to content

News

Cell line development partners deliver technology breakthrough

12 April 2021

A project consortium involving Solentim, ValitaCell and Microcoat has successfully developed an integrated technology platform for biologics and cell therapy. In 2019, the consortium partners raised €3.5M to advance the project...

Read More
19 March 2021

ValitaCell shortlisted for prestigious innovation award

ValitaCell's Quantum 'At-line' innovation was shortlisted by the Irish Times expert panel for the Innovation...
Read More
19 March 2021

ValitaCell Head of Data speaks at virtual bioprocessing conference

ValitaCell's Head of Data, Dr. Paul Dobson, spoke at the inaugural, Irish virtual bioprocessing conference....
Read More
19 March 2021

ValitaCell selected for Startup Creasphere accelerator

ValitaCell, has been selected as one of 11 high potential global start-ups to join the...
Read More
18 March 2021

ValitaCell recruits for growth

ValitaCell recorded record revenues in 2020 and has set aggressive growth targets for 2021. To...
Read More
18 March 2021

EU patent approved for ChemStress®

One of ValitaCell's key goals is to improve process control for cell based manufacturing systems...
Read More
18 March 2021

EU patents approved for Quantum

Quantum is ValitaCell's pioneering technology that powers a range of products including VALITA®TITER. Innovation and...
Read More